Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma
Kotaro Higashi(Kanazawa Medical University), Hisao Tonami, Seiji Niho(Dokkyo Medical University), Kengo Ito(National Center for Geriatrics and Gerontology), Yoshimichi Ueda(Kanazawa Medical University), Takashi Kato(National Center for Geriatrics and Gerontology), Tomoko Takahashi(Kyoto Prefectural University of Medicine), Ryuzo Sekiguchi(Tochigi Cancer Center), Tsutomu Sakuma, Takeshi Kobayashi(Nihon Institute of Medical Science)
Cited by 24
Related Papers
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2017|1.2k
Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET
|NeuroImage|2002|839
A Randomized Controlled Trial of Multicomponent Exercise in Older Adults with Mild Cognitive Impairment
|PLoS ONE|2013|388
Somatosensory Homunculus as Drawn by MEG
|NeuroImage|1998|342